Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model
- 11 November 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (47), 6589-6596
- https://doi.org/10.1038/sj.onc.1203073
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 33 references indexed in Scilit:
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Prognosis and prediction of response in breast cancer: the current role of the main biological markersCell Proliferation, 1998
- Prognosis and prediction of response in breast cancer: the current role of the main biological markersCell Proliferation, 1998
- Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic miceOncogene, 1997
- Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein KinasesPublished by Elsevier ,1996
- Response of normal and oncogene-transformed human mammary epithelial cells to transforming growth factor β1 (TGF-β1): Lack of growth-inhibitory effect on cells expressing the simian virus 40 large-t antigenInternational Journal of Cancer, 1994
- Infrequent p53 mutations in 7,12‐dimethylbenz[a]anthracene–induced mammary tumors in BALB/c and p53 hemizygous miceMolecular Carcinogenesis, 1994
- Guidelines for implementation of clinical DNA cytometryCytometry, 1993
- TGF‐β regulation of epithelial cell proliferationMolecular Reproduction and Development, 1992
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984